The great opportunity of the andrological patient: cardiovascular and metabolic risk assessment and prevention

Andrology

14 March Mar 2017 9 months ago
  • Montorsi P

Andrologists, cardiologists and diabetologists (and general practitioners) have the great opportunity to collaborate and find shared clinical workup for the benefit of a large number of men. Several evidence established a link between erectile dysfunction (ED), cardiovascular disease (CVD), diabetes, and metabolic syndrome. Not only these conditions share many risk factors and pathophysiological mechanisms but also an emerging paradigm indicates that ED is, in fact, an independent marker of cardiovascular disease risk, CV events and CV mortality. However, there is no consensus on the best cardiologic investigation in men with ED with no known CVD and, on the contrary, on what is the clinical and prognostic role of detecting ED during cardiovascular investigation and CVD risk assessment.

Sexual symptoms (and testosterone levels) should sound as harbinger for cardiovascular and metabolic investigation and cardiologists and diabetologists have the opportunity to have a symptom (erectile dysfunction) and a vascular test (penile color doppler) that help them in better management of patients, their comorbidities and complications.

Reference

  • Foresta C, Ferlin A, Lenzi A, Montorsi P; Italian Study Group on Cardiometabolic Andrology. The great opportunity of the andrological patient: cardiovascular and metabolic risk assessment and prevention. Andrology 2017 Mar 7[Epub ahead of print] Go to PubMed